{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:39:07Z","timestamp":1792075147900,"version":"4.4.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Infect Dis Clin Pract"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      The aim of our study is to evaluate risk factors associated with the development of\n                      <jats:italic toggle=\"yes\">Clostridium difficile<\/jats:italic>\n                      infection (CDI) in hematopoietic stem cell transplant (HSCT) patients, determine its incidence, and report outcomes of CDI in our patient population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective review of medical records of adult HSCT recipients diagnosed between 2013 and 2016 at our center. Logistic regression models were used to determine the relationship between risk factors and the odds of CDI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall incidence of CDI in HSCT patients was 9.4%. The incidence of CDI was higher in allogeneic HSCT (20%) versus autologous HSCT (4.8%). No statistically significant differences in age, sex, cancer type, and transplant type were found between those who developed CDI and those who did not. However, patients with CDI had a longer length of stay (25 days) and used more antibiotics (30 days prior to and during admission for HSCT) than non-CDI patients (19 days). Only 2 of 17 patients (11.8%) with CDI experienced recurrence among 180 patients after HSCT. No patient suffered from toxic megacolon or ileus, and no patient underwent colectomy. There was no mortality associated with CDI at our center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Clostridium difficile<\/jats:italic>\n                      infection has an incidence rate of 9.4% in HSCT recipients. Established risk factors including age, sex, cancer type, and transplant type were not identified as risk factors in our population. However, longer LOS and use of more than 4 lines of antibiotics were observed among those with CDI compared with those without CDI.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ipc.0000000000000798","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T14:38:07Z","timestamp":1574087887000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["A Single-Center Experience and Literature Review of Management Strategies for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Patients"],"prefix":"10.1097","volume":"28","author":[{"given":"Aneela","family":"Majeed","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marti M.","family":"Larriva","sequence":"additional","affiliation":[{"name":"Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Iftikhar","sequence":"additional","affiliation":[{"name":"Medicine, University of Arizona, Tucson, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeela","family":"Mushtaq","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh Medical Center, McKeesport, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Campbell","sequence":"additional","affiliation":[{"name":"Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Nadeem","family":"Malik","sequence":"additional","affiliation":[{"name":"Medicine, University of Arizona, Tucson, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Rafae","sequence":"additional","affiliation":[{"name":"Department of Medicine, McLaren-Flint, Michigan State University, Flint, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Abu","family":"Zar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jacobi Medical Center, Bronx"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Kamal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Suny Downstate Medical Center, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midhat","family":"Lakhani","sequence":"additional","affiliation":[{"name":"Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nageena Rani","family":"Khalid","sequence":"additional","affiliation":[{"name":"Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirdad T.","family":"Zangeneh","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Department of Medicine, University of Arizona, Tucson, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"issue":"7","key":"bib1-20251208","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"13","key":"bib2-20251208","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care\u2013associated infections","volume":"370","year":"2014","journal-title":"N Engl J Med"},{"issue":"24","key":"bib3-20251208","first-page":"2369","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"bib4-20251208","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.bbmt.2014.02.022","article-title":"Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis","volume":"20","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"bib5-20251208","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.bbmt.2014.04.026","article-title":"Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation","volume":"20","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"bib6-20251208","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1590\/S0036-46652014000400010","article-title":"Incidence of diarrhea by Clostridium difficile in hematologic patients and hematopoietic stem cell transplantation patients: risk factors for severe forms and death","volume":"56","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"10","key":"bib7-20251208","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.bbmt.2013.07.022","article-title":"Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors","volume":"19","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"bib8-20251208","article-title":"Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients","volume":"4","year":"2015","journal-title":"Antimicrob Resist Infect Control"},{"issue":"8","key":"bib9-20251208","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/cid\/cir1035","article-title":"Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients","volume":"54","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"bib10-20251208","doi-asserted-by":"crossref","first-page":"e90158","DOI":"10.1371\/journal.pone.0090158","article-title":"Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation","volume":"9","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"bib11-20251208","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.bbmt.2014.06.025","article-title":"Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1\/027","volume":"20","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"bib12-20251208","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.bbmt.2012.02.010","article-title":"Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome","volume":"18","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"bib13-20251208","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbmt.2012.10.030","article-title":"Changing epidemiology of Clostridium difficile\u2013associated disease during stem cell transplantation","volume":"19","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"bib14-20251208","article-title":"Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation","volume":"25","year":"2011","journal-title":"Clin Transplant"},{"issue":"5","key":"bib15-20251208","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Pt 3","key":"bib16-20251208","first-page":"209","article-title":"Risk factors, outcomes and epidemiology associated with Clostridium difficile infection in patients with haematological malignancies in a tertiary care hospital in China","volume":"64","year":"2015","journal-title":"J Med Microbiol"},{"issue":"8","key":"bib17-20251208","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.bmt.1702627","article-title":"Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality","volume":"26","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"bib18-20251208","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1399-0012.2009.01035.x","article-title":"Clostridium difficile\u2013associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes","volume":"24","year":"2010","journal-title":"Clin Transplant"},{"issue":"6","key":"bib19-20251208","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ctr.12737","article-title":"Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation","volume":"30","year":"2016","journal-title":"Clin Transplant"},{"issue":"2","key":"bib20-20251208","doi-asserted-by":"crossref","first-page":"ofx050","DOI":"10.1093\/ofid\/ofx050","article-title":"Infections in hematopoietic cell transplant recipients: results from the organ transplant infection project, a multicenter, prospective, cohort study","volume":"4","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"bib21-20251208","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/ice.2017.12","article-title":"Evaluating risk factors for Clostridium difficile infection in stem cell transplant recipients: a national study","volume":"38","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"bib22-20251208","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40121-016-0124-z","article-title":"Clostridium difficile infection in special high-risk populations","volume":"5","year":"2016","journal-title":"Infect Dis Ther"},{"issue":"11","key":"bib23-20251208","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1017\/ice.2015.177","article-title":"Impact of toxigenic Clostridium difficile colonization on the risk of subsequent C. difficile infection in intensive care unit patients","volume":"36","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"bib24-20251208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157489110790112608","article-title":"Clostridium difficile infection following chemotherapy","volume":"5","year":"2010","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"5","key":"bib25-20251208","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/tid.12112","article-title":"Risk factors, preemptive therapy, and antiperistaltic agents for Clostridium difficile infection in cancer patients","volume":"15","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"bib26-20251208","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhin.2008.06.026","article-title":"A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics","volume":"70","year":"2008","journal-title":"J Hosp Infect"},{"issue":"9759","key":"bib27-20251208","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","article-title":"Clostridium difficile infection in Europe: a hospital-based survey","volume":"377","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"bib28-20251208","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/infdis\/jix011","article-title":"Protective factors in the intestinal microbiome against Clostridium difficile infection in recipients of allogeneic hematopoietic stem cell transplantation","volume":"215","year":"2017","journal-title":"J Infect Dis"},{"issue":"1","key":"bib29-20251208","article-title":"Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period","volume":"19","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"bib30-20251208","article-title":"Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: a single-center study in Qu\u00e9bec, Canada","volume":"19","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"bib31-20251208","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"bib32-20251208","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bjhh.2015.07.010","article-title":"Clostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation","volume":"37","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"10","key":"bib33-20251208","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/sj.bmt.1701773","article-title":"Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation","volume":"23","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"bib34-20251208","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.bmt.1702086","article-title":"High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients","volume":"25","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"bib35-20251208","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/clinids\/24.3.324","article-title":"Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial","volume":"24","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"6","key":"bib36-20251208","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","article-title":"Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"issue":"9251","key":"bib37-20251208","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(00)03592-3","article-title":"Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea","volume":"357","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"bib38-20251208","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/clinids\/18.2.181","article-title":"Clostridium difficile colonization and diarrhea at a tertiary care hospital","volume":"18","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"9103","key":"bib39-20251208","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(97)08062-8","article-title":"Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea","volume":"351","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"bib40-20251208","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/sj.bmt.1705269","article-title":"Incidence of Clostridium difficile\u2013associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma","volume":"37","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"bib41-20251208","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/phar.1914","article-title":"Evaluation of risk factors for Clostridium difficile infection in hematopoietic stem cell transplant recipients","volume":"37","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"5","key":"bib42-20251208","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"issue":"20 Suppl 2","key":"bib43-20251208","first-page":"1","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"bib44-20251208","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2334-13-148","article-title":"Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy","volume":"13","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"2","key":"bib45-20251208","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1086\/511792","article-title":"Severity of Clostridium difficile\u2013associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system","volume":"28","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"bib46-20251208","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile\u2013associated diarrhea, stratified by disease severity","volume":"45","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"18","key":"bib47-20251208","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile\u2014more difficult than ever","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"bib48-20251208","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa1602615","article-title":"Bezlotoxumab for prevention of recurrent Clostridium difficile infection","volume":"376","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"bib49-20251208","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1038\/ajg.2010.254","article-title":"Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence","volume":"105","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"bib50-20251208","doi-asserted-by":"crossref","first-page":"839","DOI":"10.7326\/0003-4819-155-12-201112200-00007","article-title":"Comparative effectiveness of Clostridium difficile treatments: a systematic review","volume":"155","year":"2011","journal-title":"Ann Intern Med"},{"issue":"9","key":"bib51-20251208","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"issue":"29","key":"bib52-20251208","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/j.vaccine.2012.01.056","article-title":"Clostridium difficile: development of a novel candidate vaccine","volume":"30","year":"2012","journal-title":"Vaccine"},{"issue":"13","key":"bib53-20251208","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.vaccine.2012.01.065","article-title":"Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine","volume":"30","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"bib54-20251208","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2004.11.004","article-title":"Clostridium difficile toxoid vaccine in recurrent C. difficile\u2013associated diarrhea","volume":"128","year":"2005","journal-title":"Gastroenterology"}],"container-title":["Infectious Diseases in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IPC.0000000000000798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:02:01Z","timestamp":1765206121000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IPC.0000000000000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ipc.0000000000000798","relation":{},"ISSN":["1536-9943","1056-9103"],"issn-type":[{"value":"1536-9943","type":"electronic"},{"value":"1056-9103","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,15]]}}}